Inventor
KUGIMIYA AKIRA
JP16 patents
⚠️ This page may combine multiple inventors who share the name “KUGIMIYA AKIRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIONOGI & CO
7 patentsUS7842692B2Nov 30, 2010
Azaindole derivative having PGD2 receptor antagonistic activity
SHIONOGI & CO13 citations81
US7956082B2Jun 7, 2011
Indole derivative having PGD2 receptor antagonist activity
SHIONOGI & CO17 citations79
US9315535B2Apr 19, 2016
Nucleoside and nucleotide having nitrogen-containing heterocycle structure
SHIONOGI & CO15 citations77
US10940201B2Mar 9, 2021
Nucleic acid derivative having immunostimulatory activity
SHIONOGI & CO2 citations68
US6765096B1Jul 20, 2004
Tricyclic compound having acyloxymethoxycarbonyl side chain
SHIONOGI & CO6 citations56
US9440938B2Sep 13, 2016
Sulfonamide derivative having PGD2 receptor antagonistic activity
SHIONOGI & CO0 citations50
US11638717B2May 2, 2023
Complex of nucleic acid medicine and multibranched lipid
SHIONOGI & CO0 citations47
KUGIMIYA AKIRA
4 patentsUS8143285B2Mar 27, 2012
Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
KUGIMIYA AKIRA23 citations91
US8993763B2Mar 31, 2015
Sulfonamide derivative having PGD2 receptor antagonistic activity
KUGIMIYA AKIRA8 citations81
US8153793B2Apr 10, 2012
Sulfonamide derivative having PGD2 receptor antagonistic activity
KUGIMIYA AKIRA4 citations71
US8623903B2Jan 7, 2014
Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
KUGIMIYA AKIRA0 citations50
UESUGI MOTONARI
3 patentsUS8207196B2Jun 26, 2012
Compositions and methods for the treatment of metabolic disorders
UESUGI MOTONARI16 citations90
US8927578B2Jan 6, 2015
Compositions and methods for the treatment of metabolic disorders
UESUGI MOTONARI8 citations82
US8778976B2Jul 15, 2014
Compositions and methods for the treatment of metabolic disorders
UESUGI MOTONARI6 citations82